To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
44 Current news about the topic anxietyrss
Through analysis of the human genome, Basle scientists have identified molecules and compounds that are related to human memory. In a subsequent pharmacological study with one of the identified compounds, the scientists found a drug-induced reduction of aversive memory. This could have ...
MIT study finds that ghrelin, produced during stressful situations, primes the brain for post-traumatic stress disorder
About a dozen years ago, scientists discovered that a hormone called ghrelin enhances appetite. Dubbed the "hunger hormone," ghrelin was quickly targeted by drug companies seeking treatments for obesity — none of which have yet panned out. MIT neuroscientists have now discovered that ...
A team of researchers led by Prof. Young-Tae Chang from National University of Singapore and Prof. Yoon-Kyoung Cho from Ulsan National Institute of Science and Technology (UNIST), Korea, developed a fluorescent caffeine detector and a detection kit that lights up like a traffic light when ...
Surprise finding shows oxytocin strengthens bad memories and can increase fear and anxiety
It turns out the love hormone oxytocin is two-faced. Oxytocin has long been known as the warm, fuzzy hormone that promotes feelings of love, social bonding and well-being. It's even being tested as an anti-anxiety drug. But new Northwestern Medicine® research shows oxytocin also can cause ...
Mouse embryos with the human enzyme CYP2C19 in the brain develop a smaller hippocampus and anxiety-like behaviour as adults. The results of this new study, which is published in the journal Molecular Psychiatry, agree in principle with earlier genetic findings in humans, and can improve ...
Unique structural insights from CRF1 structure will drive drug discovery programmes targeting important Class B GPCRs including GLP1 (diabetes)
Heptares Therapeutics announces the publication of a scientific article describing the high resolution X-ray crystal structure of the corticotropin-releasing factor receptor 1 (CRF1) receptor in Nature.CRF1 is the receptor for the hormone CRF, which is important in regulating the body’s ...
African-American, Hispanic children significantly less likely to have received gastroenterology, psychitry or psychology care, procedure
A study from investigators at MassGeneral Hospital for Children (MGHfC) found that African-American or Hispanic children diagnosed with autism were significantly less likely than white children to have received subspecialty care or procedures related to conditions that often accompany autism ...
Both daughters and sons from divorced families are significantly more likely to initiate smoking in comparison to their peers from intact families, shows a new analysis of 19,000 Americans. This University of Toronto study, published online this month in the journal Public Health, shows that ...
Companies to Collaborate on Central Nervous System Disorder Opportunity
Ironwood Pharmaceuticals, Inc. and Bionomics Limited announced that they entered into a collaboration, research, and licensing agreement that will enable Ironwood to develop and commercialize Bionomics’ investigational anti‐anxiety compound BNC210 and other related compounds. The goal of the ...
BNC210 significantly reduced panic symptoms and faster than placebo
Bionomics Limited has successfully concluded two Phase Ib clinical trials of BNC210 which is being developed as a new generation treatment for anxiety and depression. The two trials of BNC210 were initiated in France in October 2010 following approval by the French Medical Agency AFSSAPS ...